Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles

L Galluzzi, JM Bravo-San Pedro, B Levine… - Nature reviews Drug …, 2017 - nature.com
… the therapeutic potential of autophagy modulators, analyse the obstacles that have limited
their development and propose strategies that may unlock the full therapeutic potential of …

[HTML][HTML] NK cells and solid tumors: therapeutic potential and persisting obstacles

L Tong, C Jiménez-Cortegana, AHM Tay, S Wickström… - Molecular cancer, 2022 - Springer
… by several factors including inadequate tumor infiltration and persistence/activation in the
tumor … potential strategies to circumvent such obstacles towards superior therapeutic activity. …

Pharmacological modulation of nucleic acid sensors—therapeutic potential and persisting obstacles

C Vanpouille-Box, JA Hoffmann… - Nature reviews Drug …, 2019 - nature.com
… data demonstrating the vast therapeutic potential of NAS-targeting molecules, identify the
obstacles preventing the complete realization of such potential and formulate strategies to …

Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles

M Bonora, MR Wieckowski, DA Sinclair… - Nature Reviews …, 2019 - nature.com
therapeutic potential of targeting mitochondria in patients with cardiovascular disease,
examine the obstacles … strategies that might empower the full clinical potential of this approach. …

Translating the therapeutic potential of neurotrophic factors to clinical 'proof of concept': a personal saga achieving a career-long quest

RT Bartus - Neurobiology of disease, 2012 - Elsevier
potential to the clinic have been disappointing, largely due to significant delivery obstacles.
… of this class of molecules persisted? The unique features of neurotrophic factors and the …

[HTML][HTML] Major biological obstacles for persistent cell-based regeneration of articular cartilage

AF Steinert, SC Ghivizzani, A Rethwilm… - … research & therapy, 2007 - Springer
… Although proof of principle has been provided that implanted chondrocytes can contribute
to structural cartilage repair, the origin of cells persisting at the repair site, whether these are …

HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to …

SM Crowe, S Sonza - Journal of leukocyte biology, 2000 - academic.oup.com
During highly active antiretroviral therapy (HAART), HIV-1 can still persist in circulating,
resting CD4 + T lymphocytes, lymph node mononuclear cells, and seminal cells of patients …

Shattering barriers toward clinically meaningful MSC therapies

O Levy, R Kuai, EMJ Siren, D Bhere, Y Milton… - Science …, 2020 - science.org
persisted in a subsequent 52-week follow-up (~56% in treated group versus ~38% in placebo
group), demonstrating the potential of … to fully unleash the therapeutic potential of MSCs. …

New drug candidates and therapeutic targets for tuberculosis therapy

Y Zhang, K Post-Martens, S Denkin - Drug discovery today, 2006 - Elsevier
… allowing for the prolonged survival and persistence of the bacilli [5]… persisting bacilli. Much
research effort focuses on understanding the biology of persistence and developing therapies

Overcoming the obstacles to gene therapy

T Friedmann - Scientific American, 1997 - JSTOR
… One group of ideal target cells for retrovirus vectors consists of so-called stem cells, which
persist indefinitely and also produce more specialized descendant cells. Blood-forming stem …